• Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy

Browse Tag

Avance Clinical

May 7, 2021
Pharmaceutical News

Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical, has expanded its gene technology clinical trial services to meet the increasing global demand predicted to reach $17.4 billion by 2023. Avance Clinical is accredited as

More
March 12, 2021

Avance Clinical Client Atossa Therapeutics Announces Final Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for COVID-19

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO

January 18, 2022

Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022

ADELAIDE, Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for

Pharmaceutical News

Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022

January 18, 2022

ADELAIDE, Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has secured a significant investment from

More
Pharmaceutical News

Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand

May 7, 2021

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical, has expanded

More
Pharmaceutical News

Avance Clinical Client Atossa Therapeutics Announces Final Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for COVID-19

March 12, 2021

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical congratulated Atossa

More
  • Navigating Regulatory Compliance in the Pharmaceutical Industry
  • How To Effectively Engage With Indonesian Authorities For Medical Device Approval
  • Quotient Sciences Appoints Thierry Van Nieuwenhove as New CEO
  • mRNA Drugs: Pros, Cons, and Prospects
  • Repurposing the anthelmintic drug Niclosamide

© 2010-2022 PharmaMirror.com - All Rights Reserved.

  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy
Go toTop